Variant report
Variant | nsv521220 |
---|---|
Chromosome Location | chr4:3713599-3714185 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs16844797 | chr4:3713599-3713600 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs77230496 | chr4:3713630-3713631 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs575720121 | chr4:3713656-3713657 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11936103 | chr4:3713660-3713661 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541480268 | chr4:3713673-3713674 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561969603 | chr4:3713704-3713705 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534713461 | chr4:3713705-3713706 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
8 | rs28622356 | chr4:3713710-3713711 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs541747086 | chr4:3713725-3713726 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1569901 | chr4:3713726-3713727 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs533412478 | chr4:3713750-3713751 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549899162 | chr4:3713764-3713765 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11945523 | chr4:3713834-3713835 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs372235193 | chr4:3713857-3713858 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572225720 | chr4:3713946-3713947 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529410200 | chr4:3713953-3713954 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375433814 | chr4:3713962-3713963 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568276086 | chr4:3713963-3713964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533958318 | chr4:3713975-3713976 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141228056 | chr4:3714010-3714011 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs570650515 | chr4:3714023-3714024 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2180258 | chr4:3714026-3714027 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs1569900 | chr4:3714030-3714031 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs575607285 | chr4:3714040-3714041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs60420070 | chr4:3714041-3714042 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs555031669 | chr4:3714112-3714113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534229720 | chr4:3714114-3714115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541264269 | chr4:3714157-3714158 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2748788 | chr4:3714185-3714186 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Retinitis pigmentosa | 18421352 | CNVD |
Wolf-Hirschhorn syndrome | 19259404 | CNVD |
Bladder cancer | 19242612 | CNVD |
Breast cancer | 19242612 | CNVD |
Congenital anomalies of the kidney and urinary tract | 19242612 | CNVD |
abnormal development | 18461090 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 21544195 | CNVD |
Melanoma | 20688739 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21509527 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Lung cancer | 18438408 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:3709800-3716000 | Weak transcription | Fetal Kidney | kidney |
2 | chr4:3710600-3715600 | Weak transcription | Esophagus | oesophagus |
3 | chr4:3711600-3714400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr4:3712200-3715000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr4:3712800-3714800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr4:3713000-3714200 | Weak transcription | HSMMtube | muscle |
7 | chr4:3713000-3716000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr4:3713200-3715800 | Weak transcription | Spleen | Spleen |
9 | chr4:3713400-3713800 | Bivalent Enhancer | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
10 | chr4:3713400-3715800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr4:3713400-3715800 | Weak transcription | Pancreas | Pancrea |
12 | chr4:3713800-3715000 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |